• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of patients taking antithrombotic drugs before dental surgery.

作者信息

Yang Ju-Hsuan, Chen Hsin-Ming, Kuo Ying-Shiung, Chiang Chun-Pin

机构信息

Department of Dentistry, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

J Dent Sci. 2020 Jun;15(2):222-224. doi: 10.1016/j.jds.2020.03.012. Epub 2020 Apr 17.

DOI:10.1016/j.jds.2020.03.012
PMID:32595905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7305421/
Abstract
摘要

相似文献

1
Management of patients taking antithrombotic drugs before dental surgery.牙科手术前服用抗血栓药物患者的管理
J Dent Sci. 2020 Jun;15(2):222-224. doi: 10.1016/j.jds.2020.03.012. Epub 2020 Apr 17.
2
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood.合成抑制剂DX-9065a对Xa因子的失活作用在人体血液中会引发强烈的抗凝和抗血小板作用。
Blood Coagul Fibrinolysis. 1999 Dec;10(8):495-501. doi: 10.1097/00001721-199912000-00007.
3
Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies.出血事件期间口服抗血小板和抗凝治疗的逆转剂：当前策略
Curr Pharm Des. 2017;23(9):1406-1423. doi: 10.2174/1381612822666161205110843.
4
Management of thrombotic and cardiovascular disorders in the new millenium.新千年血栓形成与心血管疾病的管理
Clin Appl Thromb Hemost. 2003 Apr;9(2):101-8. doi: 10.1177/107602960300900202.
5
Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa.同时抑制凝血酶和Xa因子产生的协同抗血栓形成作用。
Blood Coagul Fibrinolysis. 2010 Mar;21(2):128-34. doi: 10.1097/MBC.0b013e3283358100.
6
Optimisation of oral anticoagulants for patients with atrial fibrillation within 12 months after percutaneous coronary intervention: A -analysis and systematic review.经皮冠状动脉介入治疗后12个月内心房颤动患者口服抗凝剂的优化：A分析与系统评价。
Int J Cardiol Heart Vasc. 2021 Aug 2;36:100850. doi: 10.1016/j.ijcha.2021.100850. eCollection 2021 Oct.
7
Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.利伐沙班，一种直接的Xa因子抑制剂，与阿司匹林和/或氯吡格雷联合使用可提高低剂量抗血栓活性，且不会增加家兔的出血风险。
J Thromb Thrombolysis. 2007 Aug;24(1):43-51. doi: 10.1007/s11239-007-0017-9. Epub 2007 Feb 24.
8
An update on heparins at the beginning of the new millennium.新千年伊始肝素领域的最新进展。
Semin Thromb Hemost. 2000;26 Suppl 1:5-21. doi: 10.1055/s-2000-9498.
9
Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol.接受口腔手术的直接口服抗凝剂（DOAC）治疗患者：文献综述及围手术期管理方案建议
Healthcare (Basel). 2020 Aug 20;8(3):281. doi: 10.3390/healthcare8030281.
10
Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.EP217609 的特异性和选择性特征：一种新型的可中和的双重作用抗凝剂，靶向凝血酶和因子 Xa。
Blood. 2012 Mar 8;119(10):2187-95. doi: 10.1182/blood-2011-09-381764. Epub 2011 Dec 5.

引用本文的文献

1
Flapless Guided Dental Implant Surgery in a Systemically Compromised Patient: A Case Report.全身状况不佳患者的无瓣引导式牙种植手术：一例报告
Cureus. 2024 Aug 23;16(8):e67582. doi: 10.7759/cureus.67582. eCollection 2024 Aug.
2
Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis.局部应用氨甲环酸预防接受牙科及小型口腔手术的抗凝患者出血：一项系统评价与荟萃分析
Healthcare (Basel). 2022 Dec 13;10(12):2523. doi: 10.3390/healthcare10122523.

本文引用的文献

1
Antithrombotic Agents.抗血栓药。
Circ Res. 2019 Feb;124(3):426-436. doi: 10.1161/CIRCRESAHA.118.313155.
2
An Update on the "Novel" and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy.新型直接口服抗凝药物和长期抗凝治疗的最新进展
Clin Chest Med. 2018 Sep;39(3):583-593. doi: 10.1016/j.ccm.2018.04.010.
3
Anticoagulation Reversal.抗凝逆转
Emerg Med Clin North Am. 2018 Aug;36(3):585-601. doi: 10.1016/j.emc.2018.04.014.
4
Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation.外科医生抗凝和抗血小板药物指南第二部分：抗血小板药物与长期抗凝的围手术期管理
Trauma Surg Acute Care Open. 2016 Jul 13;1(1):e000022. doi: 10.1136/tsaco-2016-000022. eCollection 2016.
5
Perioperative management of anticoagulant and antiplatelet therapy.抗凝和抗血小板治疗的围手术期管理
Heart. 2018 Sep;104(17):1461-1467. doi: 10.1136/heartjnl-2016-310581. Epub 2017 Dec 7.
6
Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.不同抗凝药物对关节置换术后患者并发症预防的影响：一项网状Meta分析。
Medicine (Baltimore). 2017 Oct;96(40):e8059. doi: 10.1097/MD.0000000000008059.
7
Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence.抗血小板治疗或慢性口服抗凝治疗的牙科患者管理：最新证据回顾。
Eur J Gen Pract. 2017 Dec;23(1):196-201. doi: 10.1080/13814788.2017.1350645.
8
Anticoagulation drug therapy: a review.抗凝药物治疗：综述
West J Emerg Med. 2015 Jan;16(1):11-7. doi: 10.5811/westjem.2014.12.22933. Epub 2015 Jan 12.
9
Monitoring plasma levels of factor Xa inhibitors: how, why and when?监测 Xa 因子抑制剂的血药浓度：方法、原因及时机？
Expert Rev Hematol. 2013 Apr;6(2):155-64. doi: 10.1586/ehm.13.11.
10
The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy.低分子量肝素在接受抗凝治疗的门诊口腔外科患者中的应用。
J Am Dent Assoc. 2002 Aug;133(8):1083-7. doi: 10.14219/jada.archive.2002.0333.